Pd04-03 Survival Following Neoadjuvant Targeted Therapy and Cytoreductive Nephrectomy in MRCC Patients With Tumor Thrombus; A Contemporary Multi-Institutional Series

Journal of Urology - Netherlands
doi 10.1016/j.juro.2017.02.222
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Mp28-09 Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma and Tumor Thrombus – Trends and Effect on Overall Survival

Journal of Urology
Urology
2018English

Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Metastatic Renal Cell Carcinoma With Level IV Thrombus: Contemporary Management With Complete Response to Neoadjuvant Targeted Therapy

Case Reports in Urology
2019English

Cytoreductive Nephrectomy in the Era of Targeted Therapies: A Review

BJU International
Urology
2017English

Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer

JAMA Oncology
Cancer ResearchOncology
2017English

Hypoalbuminaemia Is Associated With Mortality in Patients Undergoing Cytoreductive Nephrectomy

BJU International
Urology
2014English

Cytoreductive Nephrectomy in the Modern Era: Predictors of Use, Morbidity, and Survival

Canadian Urological Association Journal
Urology
2017English

Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy in the United States: A SEER Analysis

World Journal of Urology
Urology
2012English

Pd04-08 Prognostic Significance of Tumor Extent Into the Venous System in Patients Undergoing Surgical Treatment for Renal Cell Carcinoma With Venous Tumor Thrombus

Journal of Urology
Urology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy